Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4469128
Max Phase: Preclinical
Molecular Formula: C171H280N42O56
Molecular Weight: 3820.36
Molecule Type: Unknown
Associated Items:
ID: ALA4469128
Max Phase: Preclinical
Molecular Formula: C171H280N42O56
Molecular Weight: 3820.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C171H280N42O56/c1-85(2)65-111(201-163(262)135(91(13)14)208-143(242)93(16)186-164(263)138(96(19)221)211-159(258)122(82-217)205-153(252)113(67-87(5)6)190-128(229)76-181-146(245)120(80-215)203-152(251)112(66-86(3)4)189-126(227)58-54-109(169(268)269)188-125(226)44-36-34-32-30-28-26-24-22-23-25-27-29-31-33-35-37-45-131(232)233)144(243)180-75-127(228)187-104(41-38-62-178-170(173)174)147(246)197-115(69-89(9)10)155(254)204-121(81-216)158(257)185-92(15)142(241)192-106(55-59-132(234)235)148(247)198-114(68-88(7)8)154(253)200-117(73-101-74-177-84-184-101)157(256)193-107(56-60-133(236)237)149(248)199-116(70-90(11)12)156(255)206-123(83-218)160(259)212-140(98(21)223)167(266)202-118(72-100-48-52-103(225)53-49-100)168(267)213-64-40-43-124(213)161(260)194-105(42-39-63-179-171(175)176)150(249)210-139(97(20)222)166(265)195-108(57-61-134(238)239)151(250)209-136(94(17)219)162(261)183-77-129(230)191-119(79-214)145(244)182-78-130(231)207-137(95(18)220)165(264)196-110(141(172)240)71-99-46-50-102(224)51-47-99/h46-53,74,84-98,104-124,135-140,214-225H,22-45,54-73,75-83H2,1-21H3,(H2,172,240)(H,177,184)(H,180,243)(H,181,245)(H,182,244)(H,183,261)(H,185,257)(H,186,263)(H,187,228)(H,188,226)(H,189,227)(H,190,229)(H,191,230)(H,192,241)(H,193,256)(H,194,260)(H,195,265)(H,196,264)(H,197,246)(H,198,247)(H,199,248)(H,200,253)(H,201,262)(H,202,266)(H,203,251)(H,204,254)(H,205,252)(H,206,255)(H,207,231)(H,208,242)(H,209,250)(H,210,249)(H,211,258)(H,212,259)(H,232,233)(H,234,235)(H,236,237)(H,238,239)(H,268,269)(H4,173,174,178)(H4,175,176,179)/t92-,93-,94+,95+,96+,97+,98+,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,135-,136-,137-,138-,139-,140-/m0/s1
Standard InChI Key: KQGQCMOOSYESLB-GSMOCUCMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3820.36 | Molecular Weight (Monoisotopic): 3818.0353 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2017) Amylin and calcitonin receptor agonist, |
Source(1):